What is the appropriate evaluation and management of a nonspecific echogenic focus in the endometrium on ultrasound?

Nonspecific Echogenic Focus in the Endometrium

A nonspecific echogenic focus in the endometrium requires further characterization with saline infusion sonohysterography to distinguish between benign entities (most commonly endometrial polyps or microcalcifications) and pathology requiring tissue diagnosis, with management determined by menopausal status, endometrial thickness, and presence of abnormal bleeding.

Clinical Context and Risk Stratification

The finding of an echogenic focus in the endometrium is most commonly benign, representing microcalcifications, crystals, or debris 1. However, the clinical significance depends critically on:

• Menopausal status
• Presence or absence of abnormal uterine bleeding
• Endometrial thickness
• Whether the focus is within fluid or solid endometrium

Postmenopausal Women

With Abnormal Bleeding

If endometrial thickness ≥5 mm or the echogenic focus is within fluid, endometrial sampling is mandatory 2. The ACR guidelines are clear that while transvaginal ultrasound can detect abnormalities, it cannot reliably determine etiology of endometrial findings 2.

• Echogenic fluid is a critical red flag: When echogenic material is present within endometrial fluid, the odds ratio for malignancy or hyperplasia increases to 10.94 (95% CI: 2.67-44.84) 3
• If endometrial thickness <4 mm, the negative predictive value for cancer approaches 100% 2
• Exception: Even with thin endometrium (≤3 mm), if fluid is echogenic, endometrial sampling is still indicated 3

Without Bleeding (Incidental Finding)

If the echogenic focus is discovered incidentally in an asymptomatic postmenopausal woman:

• Endometrial thickness <4 mm with clear (non-echogenic) fluid: No immediate intervention required 3
• Consider endocervical sampling to exclude endocervical cancer, as 2 cases occurred with endometrial thickness ≤3 mm 3
• The prevalence of asymptomatic endometrial thickening is 10-17%, with malignancy risk approximately 0.1% in polyps 4

Premenopausal Women

Endometrial thickness is NOT a reliable indicator of pathology in premenopausal women 2. Even with thickness <5 mm, endometrial polyps or other pathology may be present 2.

With Abnormal Uterine Bleeding

• Proceed directly to saline infusion sonohysterography to characterize the echogenic focus 2
• If non-uniform endometrial echogenicity with thickness ≥7 mm: higher suspicion for atypical hyperplasia or carcinoma (OR: 8.08) 5
• Age ≥50 years increases risk substantially (OR: 3.97) 5

Without Bleeding (Incidental Finding)

• Isolated echogenic foci in asymptomatic premenopausal women are typically benign and stable over time 1
• Follow-up ultrasound showed foci remained unchanged in 72% (13/18) and disappeared in 28% (5/18) over mean 16 months 1
• No immediate intervention unless risk factors present

Sonohysterography for Characterization

Saline infusion sonohysterography is the next appropriate step when initial transvaginal ultrasound shows a focal endometrial abnormality 2.

Distinguishing Features

Sonohysterography achieves 97% accuracy in differentiating polyps from leiomyomas 2:

Endometrial Polyp:

• Intact myometrial-endometrial interface
• Single feeding vessel
• Acute angle with endometrium
• Homogeneous echogenicity

Submucosal Leiomyoma:

• Absent/disrupted endometrial-myometrial interface
• Arborized vascular pattern
• Obtuse angle with endometrium
• Heterogeneous echogenicity

Critical Limitation

Sonohysterography CANNOT distinguish benign from malignant endometrial pathology with certainty 2. Therefore, endometrial sampling or hysteroscopy with directed biopsy remains necessary when pathology is suspected 2.

When to Proceed to Tissue Diagnosis

Absolute indications for endometrial sampling/hysteroscopy:

• Postmenopausal bleeding with endometrial thickness ≥5 mm 2
• Echogenic fluid in endometrial cavity (any age) 3
• Premenopausal women with abnormal bleeding and cystic/non-uniform endometrium with thickness ≥7 mm 5
• Any focal endometrial abnormality that persists or cannot be fully characterized 2

Alternative Imaging: MRI

If ultrasound is inconclusive or the uterus cannot be completely visualized (due to position, body habitus, or coexisting pathology like large fibroids):

• MRI pelvis with gadolinium and diffusion-weighted imaging is the preferred alternative 2
• MRI sensitivity/specificity for endometrial cancer: 79%/89% 2
• MRI can visualize endometrium even with extensive adenomyosis or leiomyomas 2

Common Pitfalls to Avoid

1. Do not assume all echogenic foci are benign without considering clinical context—echogenic fluid dramatically increases malignancy risk 3
2. Do not rely on endometrial thickness alone in premenopausal women—pathology can exist with any thickness 2
3. Do not skip tissue diagnosis based on sonohysterography appearance alone—imaging cannot definitively exclude malignancy 2
4. Do not forget endocervical sampling in postmenopausal women with thin endometrium, as endocervical cancer can present this way 3